Funding for this research was provided by:
European Regional Development Fund (DRV/VALO 2017-033)
Région Auvergne-Rhône-Alpes (DRV/VALO 2017-033)
Greentech SA (DRV/VALO 2017-033)
Received: 5 December 2019
Accepted: 10 May 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: The study (and its amendment in June 2018) was approved by the Committee for the Protection of Persons (CPP) Sud-Est VI, Clermont-Ferrand, France, and The French National Agency for Medicines and Health Products Safety (ANSM) (study ref. 2016-A01640–51). The study is registered with the Clinical Trials under ID: NCT03068663. Written informed consent was obtained from all patients before enrolment in the study.
: Not applicable.
: The authors declare that they have no competing interests.